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In this thesis some of the pathophysiological pÍocesses that are involved in heart failure ,
especially due to idiopathic dilated cardiomyopathy, are described. Patients as well as
healthy volunteers were investigated with two imaging techniques, positron emission
tomography and dobutamine stress echocardiography. Myocardial perfusion and
b-adrenoceptor density were measLrred with positron emission tomography while
contracti le responses were studied using dobutamine stress echocardiography. The
development of the techniques used for investigation of the subjects is reviewed and the
results of the measurements in patients are described in this thesis.
The first rwo chapters describe myocardial perfusion measurements with positron
emission tomography in healthy volunteers and patients with left ventricular dysfunction,
both with and without signs of heart failure. The first chapter shows that positron emission
tomography with [13N]ammonia can be used to perform measurements of rnyocardial
perfusion in humans. Previous studies of myocardial perfusion using [l3NJammonia and
positron emission tomography did not use positron emission tomography to its full
potent ia l  and per fus ion was only srudied in  a semiquant i ta t ive way,  i .e .  s tat ic  posi t ron
emission tomography. Images obtained this way showed an unexpiained reduced uptake
in the posterolateral part of the heart in healthy volunteers without coronary artery
disease, in whom a homogeneous uptake was expected. This artifact was not present
using positron emission tomography to its full potential, i.e. dynamic positron emission
tomography. Dynamic positron emission tomography studies provide quantitative data
about perfusion. The posterolateral artifact during static positron emission tomography
imaging with [l3Nlammonia might be explained by the metabolism of [13N]ammonia
because static images are obtained late after injection of [13N]ammonia while dynamic
perfusion measurements use data early after the injection of [13N]ammonia. The
investigations in chapter 2 are thus performed using dynamic positron emission
tomography. In chapter 2, the relation between myocardial perfusion and severity of
heart failure was investigated. Brain (or B-type) natriuretic peptide was measured as an
objective measure of heart failure. Patients with left ventricular dysfunction without
signs of heart failure (i.e. normal brain natriuretic peptide) were compared to patients
with left ventricular dysfunction with signs of heart failure (i.e. elevated brain natriuretic
peptide) . Perfusion was studied at rest and after administration of dipyridamole to assess
myocardial perfusion reserve. Furthermore, myocardial perfusion was measured during
endothelial function testing using the cold pressor test. Although it was initially expected
that patients with higher BNP would show more abnormalities, no clear differences in
endothelial function and myocardial perfusion reserve were found; endothelial dysfunction
and myocardial perfusion reserve were equally affected in patients with and without
elevated brain natriuretic peptide. These results might suggest that abnormalities in
myocardial perfusion precede the development of heart failure in patients with ieft
ven t r icu lar  dysfu ncr ion.






































In chapters 3 , 4 and 5 measurements of myocardial b-adrenoceptor density are described.
Chapter 3 is a review discussing the measurements of myocardial b-adrenoceptor density
and focuses primarily on in uiuo measurements in humans. Although much has been
learned about the role of the b-adrenoceptor in cardiac function from in uino studies,
these measurements are by definition a limited reflection of the in uiuo condition and
because of their invasive nature do not allow longitudinal and regional assessment of
myocardial b-adrenoceptors in humans. The development of new methods to measure
b-adrenocept ors in uiuo might help us to further understand b-adrenoceptor function
and could add prognostic information and assist in clinical decisions about therapeutic
interventions. Positron emission tomography studies measuring b-adrenoceptor density
are promising and support and extend the results of in uino studies. Positron emission
tomography measurements of b-adrenoceptor density show clear differences between
patients with heart failure, showing a reduced b-adrenoceptor densiry and patients without
heart failure. Furthermore, there seems to be a reduced b-adrenoceptor density in patients
with hypertrophic cardiomyopathy, a disease that can progress to heart failure. In patients
with diseases that do not progress to heart fàilure b-adrenoceptor density was equal to
measurements in healthy volunteers, except for patients with arrhythmogenic right
ventricular cardiomyopathy. ln Chapter 4 the regional quantification of b-adrenoceptor
density is investigated. It shows that regional variations in b-adrenoceptor can be reliably
assessed. A parametric polar map approach combined with different filters was used to
assess b-adrenoceptor density in 576 segments of the left ventricle. Reliable results (more
rhan95%o f the segments having reliable values) were obtained in all subjects investigated;
9 volunteers and 4 patients. The method might be useful in the investigation of cardiac
diseases in which a regional variation in b-adrenoceptor density may be expected. 'fhe
studie s in chapters 3 and 4 were performed with the radioligand [] 1C] CG P 12177 . Since
the radiochemical synthesis of |1C]CGP 12177 is very demanding a new tracer was
developed, (S)-["C]CGP 12388. Chapter 5 shows that positron emission tomography
with (S)-[11C]CGP 12388 is applicable for the measuÍement of myocardial b-adrenoceptor
density in patients. A highly significant reduction in b-adrenoceptor density was found
in patients with idiopathic dilated cardiomyopathy compared to healthy volunteers. With
the introduction of (S)-|1C]CGP 12388, positron emission tomography could gain a
more prominent role in the pathophysiologicai nvestigation of the b-adrenoceptor in
"'o'an^orrr,6 
and,7 describe the measurement of myocardial contractile reserve in
patients with heart failure. Chapter 6 is a review describing various imaging methods
and stress protocols to assess myocardial contractile reserve in a non-ir-rvasive way. In
contrast to left ventricular performance measurements at rest, myocardial contractile
reserve indices appear to be a better parameter ofthe functional status ofthe heart and
seem to be a new prognostic marker in heart failure. The exploration of pathophysiologic
mechanisms ofheart failure and the assessment of the effect of theraoeutic interventions
may be facil i tated by these new diagnostic opporrunities. In chapter 7 one of the
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with idiopathic dilated cardiomyopathy. A majority of patients with idiopathic dilated
cardiomyopathy showed myocardial regions with a decreased wall morion during increased
dernand, i.e. an ischaemia-like myocardial contractile response during dobutamine stress
echocardiography, which is generally observed in patients with ischaemic heart disease.
These observations upport the concept that an energi/ mismatch between demand and
supply might play a parhophysiological role in idiopathic dilated cardiomyopathy.
Drscussr0N
'l'he 
studies presented in this thesis provide further evidence for the hypothesis that
myocardial ischaemia plays a pathophysiological role in the progression of left ventricular
dysfunction to heart failr-rre, both in patients with and without coronary artery disease.
A misbalance between demand and supply may lead to (progression of) heart failure. A
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Figure 1. Victous ctrcle of ischaemta leadrng to heart fatlure and hearÍ fatlure leadtng to ischaemia.
In patients with cororrary artery disease who show signs of left ventricular clysfunctior.r
but t.to signs of heart ítailure, n.ryocardial perfusion (i.c. supply) was seriously afïected,
conrprrable to patients '"vho presentecl rvith signs of heart fàilure. This suggests that
rlyocardial perfirsion abnormalit ies cotrld precede the progression ofheart faiL,rre. Patients
with idiopathic dilatccl cardiomyopathy showed dobr-rtarl ine stress (i.e. higher demancl)
inclr-rced regional wall rnotion abnornralit ies, which in patients with coronary artery
cliscasc are interprctcrcl as a sign of ischaemia. The (regional) abnormalit ies in contracti l i ty
rnight bc c:rused by a clorvr.rregulation f b-adrenoceptor, which can be sttrclied in uiuo
usi nt: positron cmission tornographr'.


















Further investigation is needed to provide more insight into the pathophysiological
mechanisms involved in the development and progression of heart failure. Abnormalities
in myocardial perfusion, b-adrenoceptor density and myocardial contractiliry should be
further explored. A relation benveen these observations can be investigated combining
the different measurements to provide more evidence that ischaemia plays a key role in
the progression of heart failure, even in patients without coronary artery disease.
Furthermore, follow up studies might provide us with information if patients with more
abnormalities in myocardial perfusion and contractiliry have a greater risk to develop
heart failure.
1 2 3
